In vivo dual-targeted chemotherapy of drug resistant cancer by rationally designed nanocarrier.

[1]  R. Tang,et al.  Yolk-shell nanostructured Fe3O4@NiSiO3 for selective affinity and magnetic separation of His-tagged proteins. , 2014, ACS applied materials & interfaces.

[2]  Xiaoqi Sun,et al.  Multifunctional Theranostic Red Blood Cells For Magnetic‐Field‐Enhanced in vivo Combination Therapy of Cancer , 2014, Advanced materials.

[3]  X. Ji,et al.  Doxorubicin-loaded silicon nanowires for the treatment of drug-resistant cancer cells. , 2014, Biomaterials.

[4]  Haijun Yu,et al.  Reversal of multidrug resistance by stimuli-responsive drug delivery systems for therapy of tumor. , 2013, Advanced drug delivery reviews.

[5]  Patrick Couvreur,et al.  Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.

[6]  Qian Wang,et al.  A Low‐Toxic Multifunctional Nanoplatform Based on Cu9S5@mSiO2 Core‐Shell Nanocomposites: Combining Photothermal‐ and Chemotherapies with Infrared Thermal Imaging for Cancer Treatment , 2013 .

[7]  Yuxin Ni,et al.  Uniform magnesium silicate hollow spheres as high drug-loading nanocarriers for cancer therapy with low systemic toxicity. , 2013, Dalton transactions.

[8]  Qianjun He,et al.  Overcoming multidrug resistance of cancer cells by direct intranuclear drug delivery using TAT-conjugated mesoporous silica nanoparticles. , 2013, Biomaterials.

[9]  Jui-Sheng Sun,et al.  Real-time visualization of pH-responsive PLGA hollow particles containing a gas-generating agent targeted for acidic organelles for overcoming multi-drug resistance. , 2013, Biomaterials.

[10]  N. Zheng,et al.  Pd nanosheet-covered hollow mesoporous silica nanoparticles as a platform for the chemo-photothermal treatment of cancer cells. , 2012, Small.

[11]  Lei Xing,et al.  Coordination Polymer Coated Mesoporous Silica Nanoparticles for pH‐Responsive Drug Release , 2012, Advanced materials.

[12]  A. Rauth,et al.  pH-Dependent doxorubicin release from terpolymer of starch, polymethacrylic acid and polysorbate 80 nanoparticles for overcoming multi-drug resistance in human breast cancer cells. , 2012, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[13]  N. Zheng,et al.  Photo‐ and pH‐Triggered Release of Anticancer Drugs from Mesoporous Silica‐Coated Pd@Ag Nanoparticles , 2012 .

[14]  Xingguo Chen,et al.  Self-templated synthesis of bifunctional Fe3O4@MgSiO3 magnetic sub-microspheres for toxic metal ions removal , 2012 .

[15]  X. Ji,et al.  A pH-responsive mesoporous silica nanoparticles-based multi-drug delivery system for overcoming multi-drug resistance. , 2011, Biomaterials.

[16]  Naomi J Halas,et al.  Theranostic nanoshells: from probe design to imaging and treatment of cancer. , 2011, Accounts of chemical research.

[17]  X. Xing,et al.  Self-assembled 3D flowerlike hierarchical Fe3O4@Bi2O3 core-shell architectures and their enhanced photocatalytic activity under visible light. , 2011, Chemistry.

[18]  Shuhong Yu,et al.  Synthesis of superparamagnetic CaCO3 mesocrystals for multistage delivery in cancer therapy. , 2010, Small.

[19]  Joseph M. DeSimone,et al.  Strategies in the design of nanoparticles for therapeutic applications , 2010, Nature Reviews Drug Discovery.

[20]  Y. Bae,et al.  Trafficking microenvironmental pHs of polycationic gene vectors in drug-sensitive and multidrug-resistant MCF7 breast cancer cells. , 2010, Biomaterials.

[21]  W. Cai,et al.  Chemical-template synthesis of micro/nanoscale magnesium silicate hollow spheres for waste-water treatment. , 2010, Chemistry.

[22]  Chun Li,et al.  Exceptionally high payload of doxorubicin in hollow gold nanospheres for near-infrared light-triggered drug release. , 2010, ACS nano.

[23]  Yuhua Shen,et al.  A Simple Method To Construct Bifunctional Fe3O4/Au Hybrid Nanostructures and Tune Their Optical Properties in the Near-Infrared Region , 2010 .

[24]  Rasmus Niemi,et al.  Targeting of porous hybrid silica nanoparticles to cancer cells. , 2009, ACS nano.

[25]  Warren C W Chan,et al.  Nanoparticle-mediated cellular response is size-dependent. , 2008, Nature nanotechnology.

[26]  Philip S Low,et al.  Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. , 2008, Accounts of chemical research.

[27]  J. Karp,et al.  Nanocarriers as an Emerging Platform for Cancer Therapy , 2022 .

[28]  I. Tannock,et al.  Drug resistance and the solid tumor microenvironment. , 2007, Journal of the National Cancer Institute.

[29]  J. Santamaría,et al.  Magnetic nanoparticles for drug delivery , 2007 .

[30]  D. Peer,et al.  Fluoxetine and reversal of multidrug resistance. , 2006, Cancer letters.

[31]  J. Dobson.  Magnetic nanoparticles for drug delivery , 2006 .

[32]  J. Reddy,et al.  Targeting therapeutic and imaging agents to folate receptor positive tumors. , 2005, Current pharmaceutical biotechnology.

[33]  M. Ferrari.  Cancer nanotechnology: opportunities and challenges , 2005, Nature Reviews Cancer.

[34]  R.J. Gillies,et al.  pH imaging , 2004, IEEE Engineering in Medicine and Biology Magazine.

[35]  Z. Siddik,et al.  Cisplatin: mode of cytotoxic action and molecular basis of resistance , 2003, Oncogene.

[36]  A. Orecchioni,et al.  Evaluation of gliadins nanoparticles as drug delivery systems: a study of three different drugs. , 2003, International journal of pharmaceutics.

[37]  P. Couvreur,et al.  Nanoparticles in cancer therapy and diagnosis. , 2002, Advanced drug delivery reviews.

[38]  M. Gottesman,et al.  Multidrug resistance in cancer: role of ATP–dependent transporters , 2002, Nature Reviews Cancer.

[39]  M. Kool,et al.  A family of drug transporters: the multidrug resistance-associated proteins. , 2000, Journal of the National Cancer Institute.

[40]  M. Dewhirst,et al.  Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size. , 2000, Cancer research.

[41]  S. Pillai,et al.  Multiple drug resistance , 1999, Medicinal research reviews.

[42]  O Pelkonen,et al.  Age and cytochrome P450‐linked drug metabolism in humans: An analysis of 226 subjects with equal histopathologic conditions , 1997, Clinical pharmacology and therapeutics.

[43]  R K Jain,et al.  Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. , 1995, Cancer research.

[44]  R. Jain,et al.  Microvascular permeability and interstitial penetration of sterically stabilized (stealth) liposomes in a human tumor xenograft. , 1994, Cancer research.

[45]  J. Ross,et al.  Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications , 1994, Cancer.

[46]  L R Coney,et al.  Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. , 1992, Cancer research.

[47]  W. Foulkes,et al.  Folate-binding protein is a marker for ovarian cancer. , 1991, Cancer research.